A woman remotely consenting using eConsent
Broader reach, higher engagement, cleaner data.

Total eConsent Management

Upgrade to a complete consent management solution for better participant access and experience.

Expand Global Access to Trials

Accessible on any web-enabled device (BYOD or provisioned), our scalable solution can inform and consent participants anywhere in the world. Flexible enough for any country or site, you can easily collect compliant signatures (digital or wet-ink), on-site or remote with integrated TeleVisit.

Improve Participant Retention

Stay connected with your patients and their data. Real-time notifications help ensure compliance while patient and caregiver-friendly ePROs make it easy for sponsors to track toxicity and tolerability in real time.

A site employee looking at their eConsents

Minimize Compliance Errors

Gain complete visibility and oversight into your trial with real-time monitoring of all consent activities within a single dashboard and ensure inspection-ready audit trails with fully integrated template management and version control.

ICON and Medable achieved 85% eConsent adoption in a U.S. menopause study through tailored training, seamless onboarding, and site-focused support.

ICON and Medable drive 85% eConsent adoption in U.S. menopause study

How do you drive adoption in a complex women’s health study? See how ICON and Medable reached 85% eConsent uptake across 1,200+ participants with a smarter, site-first approach.

PDF
Case study: ICON and Medable drive 85% eConsent adoption in U.S. menopause study

Frequently asked questions

What is agentic AI in clinical development?

Agentic AI refers to autonomous, goal-driven AI systems—often called “agents”—that can reason, plan, and act in complex environments with minimal human intervention. In clinical development, these agents can manage and optimize trial workflows such as protocol design, patient recruitment, site coordination, and regulatory documentation. Unlike traditional automation, which follows static rules, agentic AI adapts to new information, learns from trial progress, and proactively orchestrates tasks to keep studies on track and compliant.

What are the benefits of AI agents for clinical trials?

AI agents help clinical trials run faster, more efficiently, and with greater quality. By automating repetitive tasks, adapting protocols in real time, and reducing human error, they streamline operations across sites while ensuring compliance and consistency. They also enable more patient-centric approaches by improving communication and engagement, ultimately making it easier to scale complex global trials with fewer resources.

Q: How do you ensure agentic recommendations are trustworthy and free from data quality issues?

Delivering trustworthy Agent recommendations requires two key elements:

The AI Model – We select and fine-tune models that are purpose-built for life sciences, trained on high-quality, relevant data. This ensures the model understands domain-specific language, context, and regulatory requirements, reducing the risk of inaccurate or irrelevant outputs.

The Agentic Environment & Verification Process – Agents operate in a controlled environment with rigorous validation checkpoints, business logic guardrails, and real-time monitoring. Every recommendation is subject to verification workflows and data quality checks before it’s surfaced to users, ensuring accuracy, compliance, and auditability.

Remove this

Remove this

The latest from Medable

An older user consents to a clinical trial using eConsent
White Papers, Case Studies, Reports

Case study: ICON and Medable drive 85% eConsent adoption in U.S. menopause study

How do you drive adoption in a complex women’s health study? See how ICON and Medable reached 85% eConsent uptake across 1,200+ participants with a smarter, site-first approach.

White Papers, Case Studies, Reports

Medable oncology solutions

Discover how Medable’s AI-powered oncology platform simplifies complex cancer trials by integrating eCOA, ePRO, and eConsent solutions—reducing trial time, improving patient retention, and enhancing data quality for faster, more efficient research.

White Papers, Case Studies, Reports

Case study: Driving a high-adherence LTFU trial without an EDC

Learn how Medable is powering a decade-long, global long-term follow-up (LTFU) obesity study, achieving an impressive 97% patient retention rate without using a traditional EDC system all while delivering a compliant, scalable, and cost-efficient solution.

See how Agent Studio can transform your trials.